Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,478,695
-$1,769,305 QoQ
Shares Held
295,787
+0.3% QoQ
Ownership
0.572%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Voss Capital, LP holds $23,022,315 across 6 Biotechnology names. RGNX ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
605,000 | $9,891,750 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
4,388,362 | $5,704,870 | |
| 3 | ACTU |
Actuate Therapeutics, Inc.
|
1,725,000 | $4,726,500 | |
| 4 | RGNX |
REGENXBIO Inc.
This page
|
295,787 | $2,478,695 | |
| 5 | CGTX |
Cognition Therapeutics Inc
|
200,000 | $152,000 | |
| 6 | LTRN |
Lantern Pharma Inc.
|
50,000 | $68,500 |
All Filings in RGNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,478,695 | 295,787 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,248,000 | 295,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,825,000 | 500,000 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $4,720,750 | 575,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,788,500 | 390,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,572,652 | 332,814 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||